Reference number : 276-2017-2018-Q3-00176, amendment number : , agreement type : C, recipient legal name : Appili Therapeutics Inc.|Appili Therapeutics Inc., recipient country : CA, recipient province : NS, recipient city : Halifax|Halifax, recipient postal code : B3H 0A8, program name english : Business Development Program, program name french : Programme de développement des entreprises, program purpose english : nan, program purpose french : nan, agreement title english : 210245, agreement title french : 210245, agreement number : 210245, agreement value : 500000.0, agreement start date : 2017-12-19, agreement end date : 2018-06-30, description english : Expansion of product pipeline in anti-infective pharmaceuticals, description french : Élargir portefeuille de produits dans secteur des produits pharmaceutiques anti-infectieux, expected results english : nan, expected results french : nan, additional information english : The assistance type is Unconditionally Repayable Contribution., additional information french : Le type d'aide est Contribution à remboursement inconditionnel., owner organization : acoa-apeca, owner organization title : Atlantic Canada Opportunities Agency | Agence de promotion économique du Canada atlantique